Caroline Kelly

About

Caroline Kelly is the Head of Biostatistics at the Cancer Research UK Glasgow Clinical Trials Unit. Her research focuses on colorectal cancer, including the impact of chemotherapy timing and the prognostic value of immunoscore in treatment outcomes. She has also explored therapeutic targets for patients with specific tumor characteristics and has contributed to studies on chemotherapy-induced peripheral neuropathy and ovarian cancer survival metrics. Based in the UK, her work is pivotal in advancing clinical trial methodologies and improving patient care in oncology.